Neoplasms, Colorectal Terminated Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02842580De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal CancerTreatment
NCT00314353Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the ColonTreatment
NCT00321100Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without BevacizumabTreatment
NCT00385021ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal CancerTreatment
NCT00609622Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal CancerTreatment